36 related articles for article (PubMed ID: 22003939)
1. Evaluating algorithms for identifying incident Guillain-Barré Syndrome in Medicare fee-for-service claims.
Eiffert SR; Wright B; Nardin J; Howard JF; Traub R
Glob Epidemiol; 2024 Jun; 7():100145. PubMed ID: 38746856
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review.
Wachira VK; Farinasso CM; Silva RB; Peixoto HM; de Oliveira MRF
Glob Epidemiol; 2023 Dec; 5():100098. PubMed ID: 37638372
[TBL] [Abstract][Full Text] [Related]
3. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
Li X; Ostropolets A; Makadia R; Shoaibi A; Rao G; Sena AG; Martinez-Hernandez E; Delmestri A; Verhamme K; Rijnbeek PR; Duarte-Salles T; Suchard MA; Ryan PB; Hripcsak G; Prieto-Alhambra D
BMJ; 2021 Jun; 373():n1435. PubMed ID: 35727911
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study.
Li X; Ostropolets A; Makadia R; Shaoibi A; Rao G; Sena AG; Martinez-Hernandez E; Delmestri A; Verhamme K; Rijnbeek PR; Duarte-Salles T; Suchard M; Ryan P; Hripcsak G; Prieto-Alhambra D
medRxiv; 2021 Apr; ():. PubMed ID: 33791732
[TBL] [Abstract][Full Text] [Related]
5. Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.
Tavares-Da-Silva F; Mahaux O; Van Holle L; Haguinet F; Seifert H; Stegmann JU
Drug Saf; 2020 Dec; 43(12):1223-1234. PubMed ID: 32862397
[TBL] [Abstract][Full Text] [Related]
6. A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria.
Boostani R; Ramezanzadeh F; Saeidi M; Khodabandeh M
Iran J Neurol; 2019 Apr; 18(2):64-69. PubMed ID: 31565202
[No Abstract] [Full Text] [Related]
7. Epidemiology of Guillain-Barré syndrome in Finland 2004-2014.
Sipilä JOT; Soilu-Hänninen M; Ruuskanen JO; Rautava P; Kytö V
J Peripher Nerv Syst; 2017 Dec; 22(4):440-445. PubMed ID: 29095548
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of Guillain-Barré Syndrome].
Yoshikawa H
Brain Nerve; 2015 Nov; 67(11):1305-11. PubMed ID: 26560945
[TBL] [Abstract][Full Text] [Related]
9. [Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote].
Aladro-Benito Y; Conde-Sendin MA; Muñoz-Fernández C; Pérez-Correa S; Alemany-Rodríguez MJ; Fiuza-Pérez MD; Alamo-Santana F
Rev Neurol; 2002 Oct 16-31; 35(8):705-10. PubMed ID: 12402219
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome: background incidence rates in The Netherlands.
van der Maas NA; Kramer MA; Jacobs BC; van Soest EM; Dieleman JP; Kemmeren JM; de Melker HE; Sturkenboom MC
J Peripher Nerv Syst; 2011 Sep; 16(3):243-9. PubMed ID: 22003939
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of Guillain-Barré syndrome with vaccinations.
Baxter R; Bakshi N; Fireman B; Lewis E; Ray P; Vellozzi C; Klein NP
Clin Infect Dis; 2013 Jul; 57(2):197-204. PubMed ID: 23580737
[TBL] [Abstract][Full Text] [Related]
12. Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data.
Hense S; Schink T; Kreisel SH; Marcelon L; Simondon F; Tahden M; Garbe E
Neuroepidemiology; 2014; 43(3-4):244-52. PubMed ID: 25531827
[TBL] [Abstract][Full Text] [Related]
13. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
